Section Arrow
Quote
KNSA.NASDAQ
- Kiniksa Pharmaceuticals International plc
Quotes are at least 15-min delayed:2025/12/01 11:29 EST
Regular Hours
Last
 41.76
-0.76 (-1.79%)
Day High 
42.53 
Prev. Close
42.52 
1-M High
42.98 
Volume 
69.56K 
Bid
41.59
Ask
41.8
Day Low
41.65 
Open
42.33 
1-M Low
36.56 
Market Cap 
3.22B 
Currency 美元 
P/E 91.78 
%Yield -- 
10-SMA 41.8 
20-SMA 40.4 
50-SMA 38.95 
52-W High 42.98 
52-W Low 17.82 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.45/1.35
Enterprise Value
3.23B
Balance Sheet
Book Value Per Share
7.06
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
423.24M
Operating Revenue Per Share
3.28
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands0.783-0.03-3.69%-- 
CGCCanopy Growth Corp1.142-0.028-2.39%-- 
HIMSHims & Hers Health38.5012-1.2588-3.17%74.91PE
HLNHaleon plc9.86+0.08+0.82%22.11PE
IXHLIncannex Healthcare0.368299+0.008099+2.25%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.